Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Urology

Reuters Health • The Doctor's Channel Daily Newscast

Sustained relief from OAB with long-term fesoterodine: study

NEW YORK (Reuters Health) Treatment for up to 24 months with fesoterodine (Toviaz; Pfizer Inc) may yield sustained improvement in bladder problems and health-related quality of life in adults with overactive bladder (OAB), suggest results of a post hoc...

Reuters Health • The Doctor's Channel Daily Newscast

Latest green-light laser effective for reducing large prostate volumes

NEW YORK (Reuters Health) – Treatment of benign prostatic hyperplasia with the latest version of the GreenLight photoselective vaporizing laser is effective in reducing lower urinary tract symptoms, “even in patients with larger prostates,”...

Reuters Health • The Doctor's Channel Daily Newscast

Percutaneous nephrolithotomy safe in patients with chronic kidney disease

NEW YORK (Reuters Health) – Percutaneous nephrolithotomy (PCNL) can be safely undertaken in patients with chronic kidney disease (CKD), researchers from Turkey report in the November 17th online issue of The Journal of Urology.“Our study demonstrated...